Annual ROE
-46.22%
-10.14%-28.10%
31 December 2023
Summary:
Theriva Biologics annual return on equity is currently -46.22%, with the most recent change of -10.14% (-28.10%) on 31 December 2023. During the last 3 years, it has risen by +78.83% (+63.04%). TOVX annual ROE is now -110.70% below its all-time high of 431.82%, reached on 01 December 1997.TOVX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-84.67%
-23.39%-38.17%
01 September 2024
Summary:
Theriva Biologics quarterly return on equity is currently -84.67%, with the most recent change of -23.39% (-38.17%) on 01 September 2024. Over the past year, it has dropped by -45.42% (-115.72%). TOVX quarterly ROE is now -100.62% below its all-time high of 13.61 thousand%, reached on 01 June 2000.TOVX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TOVX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.1% | -115.7% |
| 3 y3 years | +63.0% | -337.4% |
| 5 y5 years | +56.6% | -10.8% |
TOVX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -111.9% | +63.0% | -337.4% | at low |
| 5 y | 5 years | -111.9% | +63.0% | -352.3% | +26.4% |
| alltime | all time | -110.7% | +99.0% | -100.6% | +99.5% |
Theriva Biologics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -84.67%(+38.2%) |
| June 2024 | - | -61.28%(+33.2%) |
| Mar 2024 | - | -46.02%(+14.1%) |
| Dec 2023 | -46.22%(+28.1%) | -40.35%(+2.8%) |
| Sept 2023 | - | -39.25%(+1.0%) |
| June 2023 | - | -38.85%(+9.9%) |
| Mar 2023 | - | -35.36%(+8.9%) |
| Dec 2022 | -36.08%(+65.4%) | -32.48%(+11.2%) |
| Sept 2022 | - | -29.22%(+13.4%) |
| June 2022 | - | -25.76%(+14.0%) |
| Mar 2022 | - | -22.60%(+16.7%) |
| Dec 2021 | -21.81%(-82.6%) | - |
| Dec 2021 | - | -19.36%(+3.4%) |
| Sept 2021 | - | -18.72%(-19.6%) |
| June 2021 | - | -23.28%(-37.6%) |
| Mar 2021 | - | -37.33%(-67.6%) |
| Dec 2020 | -125.05%(+17.4%) | -115.11%(+7.1%) |
| Sept 2020 | - | -107.43%(-1.0%) |
| June 2020 | - | -108.47%(+20.8%) |
| Mar 2020 | - | -89.83%(+17.5%) |
| Dec 2019 | -106.53%(+134.0%) | -76.42%(+18.5%) |
| Sept 2019 | - | -64.51%(+0.0%) |
| June 2019 | - | -64.49%(-23.1%) |
| Mar 2019 | - | -83.89%(-17.7%) |
| Dec 2018 | -45.52%(-68.3%) | -101.88%(+16.8%) |
| Sept 2018 | - | -87.23%(-69.5%) |
| June 2018 | - | -286.25%(-4.6%) |
| Mar 2018 | - | -299.98%(-34.9%) |
| Dec 2017 | -143.73%(-79.7%) | -460.91%(-63.5%) |
| Sept 2017 | - | -1263.82%(+19.9%) |
| June 2017 | - | -1053.72%(-42.1%) |
| Mar 2017 | - | -1820.04%(+32.2%) |
| Dec 2016 | -708.84%(+160.1%) | -1376.34%(+93.1%) |
| Sept 2016 | - | -712.71%(+162.3%) |
| June 2016 | - | -271.70%(-44.5%) |
| Mar 2016 | - | -489.33%(-25.5%) |
| Dec 2015 | -272.49%(+31.6%) | -656.88%(-15.7%) |
| Sept 2015 | - | -779.32%(-110.3%) |
| June 2015 | - | 7576.48%(-1421.3%) |
| Mar 2015 | - | -573.39%(+140.0%) |
| Dec 2014 | -207.03%(+156.0%) | -238.88%(+32.2%) |
| Sept 2014 | - | -180.69%(+17.0%) |
| June 2014 | - | -154.40%(+18.5%) |
| Mar 2014 | - | -130.30%(+12.4%) |
| Dec 2013 | -80.87%(-38.3%) | -115.97%(-42.1%) |
| Sept 2013 | - | -200.17%(+5.1%) |
| June 2013 | - | -190.43%(-3.3%) |
| Mar 2013 | - | -196.83%(-4.3%) |
| Dec 2012 | -131.01%(+13.5%) | -205.68%(+71.0%) |
| Sept 2012 | - | -120.29%(+23.7%) |
| June 2012 | - | -97.24%(+10.4%) |
| Mar 2012 | - | -88.09%(-17.2%) |
| Dec 2011 | -115.44%(+140.3%) | -106.44%(+23.8%) |
| Sept 2011 | - | -85.98%(-9.8%) |
| June 2011 | - | -95.35%(+49.9%) |
| Mar 2011 | - | -63.61%(+33.7%) |
| Dec 2010 | -48.04% | -47.59%(-7.4%) |
| Sept 2010 | - | -51.37%(+10.9%) |
| June 2010 | - | -46.32%(-45.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | -84.20%(+17.3%) |
| Dec 2009 | -72.39%(-6.0%) | -71.77%(+21.8%) |
| Sept 2009 | - | -58.92%(-7.7%) |
| June 2009 | - | -63.85%(-6.4%) |
| Mar 2009 | - | -68.22%(-16.0%) |
| Dec 2008 | -77.02%(-7.6%) | -81.21%(-22.4%) |
| Sept 2008 | - | -104.64%(-3.7%) |
| June 2008 | - | -108.63%(+4.1%) |
| Mar 2008 | - | -104.39%(+7.2%) |
| Dec 2007 | -83.37%(+12.7%) | -97.38%(-14.4%) |
| Sept 2007 | - | -113.82%(-4.8%) |
| June 2007 | - | -119.52%(-17.4%) |
| Mar 2007 | - | -144.73%(+4.4%) |
| Dec 2006 | -73.97%(-138.4%) | -138.67%(-99.1%) |
| Sept 2006 | - | -16.00 K%(+161.7%) |
| June 2006 | - | -6112.66%(-211.5%) |
| Mar 2006 | - | 5484.04%(>+9900.0%) |
| Dec 2005 | 192.64%(+243.9%) | - |
| Mar 2003 | - | 43.06%(-32.7%) |
| Dec 2002 | 56.01%(-46.3%) | 63.99%(-28.5%) |
| Sept 2002 | - | 89.47%(-27.5%) |
| June 2002 | - | 123.35%(-20.6%) |
| Mar 2002 | - | 155.38%(-59.6%) |
| Dec 2001 | 104.32%(-102.3%) | 384.18%(-40.3%) |
| Sept 2001 | - | 643.27%(-40.7%) |
| June 2001 | - | 1085.23%(-41.5%) |
| Mar 2001 | - | 1856.43%(-201.4%) |
| Dec 2000 | -4478.79%(+76.6%) | -1831.03%(-47.8%) |
| Sept 2000 | - | -3510.88%(-125.8%) |
| June 2000 | - | 13.61 K%(+286.8%) |
| Mar 2000 | - | 3519.00%(+138.4%) |
| Dec 1999 | -2535.94%(-4.6%) | 1475.82%(+242.5%) |
| Sept 1999 | - | 430.87%(-174.6%) |
| June 1999 | - | -577.82%(-80.8%) |
| Mar 1999 | - | -3010.80%(-61.2%) |
| Dec 1998 | -2657.14%(-715.3%) | -7750.00%(-49.5%) |
| Sept 1998 | - | -15.36 K%(-645.7%) |
| June 1998 | - | 2814.81%(+472.2%) |
| Mar 1998 | - | 491.89%(-78.0%) |
| Dec 1997 | 431.82%(-208.0%) | 2235.29%(-370.0%) |
| Sept 1997 | - | -827.87%(+112.9%) |
| June 1997 | - | -388.89%(+39.2%) |
| Mar 1997 | - | -279.31%(+12.5%) |
| Dec 1996 | -400.00%(-67.6%) | -248.25%(+10.6%) |
| Sept 1996 | - | -224.36%(-33.6%) |
| June 1996 | - | -337.84%(-6.1%) |
| Mar 1996 | - | -359.81%(+1.1%) |
| Dec 1995 | -1233.33%(+7.7%) | -355.77%(+16.9%) |
| Sept 1995 | - | -304.35%(-128.1%) |
| June 1995 | - | 1083.33%(+4.8%) |
| Mar 1995 | - | 1033.33%(-604.8%) |
| Dec 1994 | -1145.45%(+399.3%) | -204.72%(+24.4%) |
| Sept 1994 | - | -164.52%(+1.8%) |
| June 1994 | - | -161.54%(+47.9%) |
| Mar 1994 | - | -109.20%(-9.7%) |
| Dec 1993 | -229.41% | -120.93%(+88.1%) |
| Sept 1993 | - | -64.29%(+166.8%) |
| June 1993 | - | -24.10%(+97.5%) |
| Mar 1993 | - | -12.20% |
FAQ
- What is Theriva Biologics annual return on equity?
- What is the all time high annual ROE for Theriva Biologics?
- What is Theriva Biologics annual ROE year-on-year change?
- What is Theriva Biologics quarterly return on equity?
- What is the all time high quarterly ROE for Theriva Biologics?
- What is Theriva Biologics quarterly ROE year-on-year change?
What is Theriva Biologics annual return on equity?
The current annual ROE of TOVX is -46.22%
What is the all time high annual ROE for Theriva Biologics?
Theriva Biologics all-time high annual return on equity is 431.82%
What is Theriva Biologics annual ROE year-on-year change?
Over the past year, TOVX annual return on equity has changed by -10.14% (-28.10%)
What is Theriva Biologics quarterly return on equity?
The current quarterly ROE of TOVX is -84.67%
What is the all time high quarterly ROE for Theriva Biologics?
Theriva Biologics all-time high quarterly return on equity is 13.61 K%
What is Theriva Biologics quarterly ROE year-on-year change?
Over the past year, TOVX quarterly return on equity has changed by -45.42% (-115.72%)